[go: up one dir, main page]

Kvajo et al., 2004 - Google Patents

Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors

Kvajo et al., 2004

View PDF @Free from Publisher
Document ID
14651950263728398188
Author
Kvajo M
Albrecht H
Meins M
Hengst U
Troncoso E
Lefort S
Kiss J
Petersen C
Monard D
Publication year
Publication venue
Journal of Neuroscience

External Links

Snippet

Serine proteases are considered to be involved in plasticity-related events in the nervous system, but their in vivo targets and the importance of their control by endogenous inhibitors are still not clarified. Here, we demonstrate the crucial role of a potent serine protease …
Continue reading at www.jneurosci.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Kvajo et al. Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors
Lüthi et al. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation
Pla et al. Dlx1 and Dlx2 promote interneuron GABA synthesis, synaptogenesis, and dendritogenesis
Jung et al. Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior
Alsabban et al. Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia‐like phenotypes in mice
Jin et al. Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior
Pei et al. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence
Chiang et al. An essential role for retinoid receptors RARβ and RXRγ in long-term potentiation and depression
Le Pichon et al. The functional and anatomical dissection of somatosensory subpopulations using mouse genetics
Song et al. Altered behaviors and impaired synaptic function in a novel rat model with a complete Shank3 deletion
Chen et al. Rac1 controls the formation of midline commissures and the competency of tangential migration in ventral telencephalic neurons
Bozza et al. Odorant receptor expression defines functional units in the mouse olfactory system
Laforet et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease
Cao et al. Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders
Mizuno et al. Evidence for activity-dependent cortical wiring: formation of interhemispheric connections in neonatal mouse visual cortex requires projection neuron activity
May et al. Connexin47 protein phosphorylation and stability in oligodendrocytes depend on expression of Connexin43 protein in astrocytes
Dhaka et al. The RAS effector RIN1 modulates the formation of aversive memories
Avasthi et al. Trafficking of membrane proteins to cone but not rod outer segments is dependent on heterotrimeric kinesin-II
Carney et al. Sonic hedgehog expressing and responding cells generate neuronal diversity in the medial amygdala
Todkar et al. Absence of the calcium-binding protein calretinin, not of calbindin D-28k, causes a permanent impairment of murine adult hippocampal neurogenesis
Xiao et al. Neurotrophic factor-α1, a novel tropin is critical for the prevention of stress-induced hippocampal CA3 cell death and cognitive dysfunction in mice: comparison to BDNF
Kiyasova et al. A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor
Mills et al. Cadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning
Hung et al. Attenuation of insulin signalling contributes to FSN-1-mediated regulation of synapse development
Zechel et al. Thalamo-cortical axons regulate the radial dispersion of neocortical GABAergic interneurons